PMDA drug package insert

アリピプラゾール錠3mg「明治」

PMDA Prescription drug · Meiji Seika ファルマ株式会社 · package insert Oct 28, 2024

Key facts

Brand names アリピプラゾール錠3mg「明治」, アリピプラゾール錠6mg「明治」, アリピプラゾール錠12mg「明治」, アリピプラゾール錠24mg「明治」, アリピプラゾールOD錠3mg「明治」, アリピプラゾールOD錠6mg「明治」, アリピプラゾールOD錠12mg「明治」, アリピプラゾールOD錠24mg「明治」, アリピプラゾール散1%「明治」
Nonproprietary names アリピプラゾール
Companies 製造販売元/Meiji Seika ファルマ株式会社
Product type Prescription drug
Therapeutic category 抗精神病薬
Therapeutic category codes 871179
YJ codes 1179045F1120, 1179045F2127, 1179045F3123, 1179045F9075, 1179045F4120, 1179045F5126, 1179045F6122, 1179045F7129, 1179045B1080
Approval numbers 22900AMX00204000, 22900AMX00205000, 22900AMX00206000, 22900AMX00207000, 22900AMX00257000, 22900AMX00258000, 22900AMX00259000, 22900AMX00260000, 22900AMX00214000
Package insert edition 第3版
Package insert date Oct 28, 2024
PMDA document key 780009_1179045B1080_1
PMDA company code 780009

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)